Novo Nordisk Inc.
- Pharmaceutical manufacturer
(2014 - 2015)
Revenue : $20,000.00 (monthly) - $310,000.00 (total)
- National Diabetes Prevention Program; Better care and treatment of people with diabetes under Pub. L. 111-148, the Patient Protection and Affordable Care Act of 2009 (ACA) and Pub. L. 111-152, the Health Care and Education Affordability Reconciliation Act of 2010; Issues related to diabetes generally; H.R. 1192/S.586, the National Diabetes Clinical Care Commission Act; H.R. 8, the American Taxpayer Relief Act(Special Diabetes Program reauthorization); The Protecting Seniors' Access to Medicar...